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Background: Behavioral interventions for obesity are commonly delivered in groups, although the effect of group size
on weight loss has not been empirically evaluated. This behavioral weight loss trial compared the 6- and 12-month
weight changes associated with interventions delivered in a large group (LG) or small groups (SG).
Methods: Obese adults (N = 66; mean age = 50 years; mean BMI = 36.5 kg/m2; 47% African American; 86% women)
recruited from a health maintenance organization were randomly assigned to: 1) LG treatment (30 members/group),
or 2) SG treatment (12 members/group). Conditions were comparable in frequency and duration of treatment, which
included 24 weekly group sessions (months 1–6) followed by six monthly extended care contacts (months 7–12). A
mixed effects model with unstructured covariance matrix was applied to analyze the primary outcome of weight
change while accounting for baseline weight and dependence among participants’ measurements over time.
Results: SG participants lost significantly more weight than LG participants at Month 6 (−6.5 vs. -3.2 kg; p = 0.03) and
Month 12 (−7.0 vs. -1.7 kg; p < 0.002). SG participants reported better treatment engagement and self-monitoring
adherence at Months 6 and 12, ps < 0.04, with adherence fully mediating the relationship between group size and
weight loss.
Conclusions: Receiving obesity treatment in smaller groups may promote greater weight loss and weight loss
maintenance. This effect may be due to improved adherence facilitated by SG interactions. These novel findings
suggest that the perceived efficiency of delivering behavioral weight loss treatment to LGs should be balanced against
the potentially better outcomes achieved by a SG approach.
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Behavioral interventions for obesity typically result in body
weight reductions of 8-10% during the initial six months of
treatment [1-3]. While treatment may be offered in group
or individual settings, it is commonly delivered in groups of
8–15 participants [1,4,5]. Studies suggest that participants
receiving group-based treatment lose significantly more
weight than those receiving one-on-one treatment [6-8].
Group-based treatment has resulted in greater weight loss
even among participants who expressed initial preference
for individual treatment [7] and when treatment was deliv-
ered by telephone (i.e., group vs. individual calls) [6].* Correspondence: gdutton@uabmc.edu
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unless otherwise stated.Potential reasons for the superior efficacy of group-based
obesity treatment include the provision of additional social
support, empathy, role-modeling of healthy choices, and a
healthy dose of competition [4,9-11]. Rooted in social-
cognitive theory [12], group-based lifestyle interventions
utilize interaction among members to promote positive
changes in self-efficacy for increased weight loss [13].
Through vicarious learning, verbal persuasion, and emo-
tional and physiological activation, group members can
impact each other and encourage behavior change [13].
While clinical experience and/or practical considerations
(e.g., space constraints) have driven the traditional delivery
of obesity treatment to groups of 8–15 individuals, research
is lacking on whether this is more efficacious than alterna-
tive group sizes. A limited number of studies in the psycho-
therapy literature compared groups of differing size for theLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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stress, but results have been mixed. While some studies
found few differences between large and small groups [14],
at least one demonstrated sustained improvements in anx-
iety symptoms and better session attendance with groups
of 10–12 members versus larger groups of 20 members
[15]. For interventions focused on changing health behav-
iors, one smoking cessation study found no association be-
tween group size and outcomes [16].
Participants within smaller groups may experience
greater benefit regarding social support [17] and group co-
hesion [18]. Group-based obesity treatments capitalize
upon positive group interactions to promote social learn-
ing, reinforcement, and support that ultimately lead to
behavior change [4,9-13]. Given there are more opportun-
ities for meaningful social interactions, smaller groups may
promote higher quality, cohesive relationships among par-
ticipants [17]. With the greater opportunity for social inter-
action and feedback, smaller groups could also promote
increased self-efficacy and adherence (e.g., session attend-
ance, completion of self-monitoring records) to treatment
recommendations [13], which are strongly associated with
weight loss success [19-23]. To our knowledge, however,
no previous study has empirically tested the effects of
group size on weight loss and related outcomes.
Examining the association between group size and treat-
ment outcomes has important clinical and practical impli-
cations for weight loss treatment. Given the limited
resources often available in applied clinical settings, treat-
ment offered in larger groups may maximize available staff
time and other organizational resources while promoting
clinically significant weight loss. However, the delivery of
group-based interventions to larger numbers of individ-
uals has not been empirically evaluated. Therefore, it is
important to compare the outcomes achieved with trad-
itional, smaller groups and larger groups, as this decision
about group sizes has direct implications for the imple-
mentation, dissemination, and sustainability of evidence-
based weight loss treatments into “real world” settings.
This study examined the effect of group size on weight
loss within a 12-month randomized behavioral weight loss
intervention delivered in a managed care setting. Partici-
pants were randomized to receive treatment in either a
“small” group (i.e., approximately 12 members per group,
SG) typical of most group-based interventions [1,4,5,15] or
a “large” group (i.e., approximately 30 members per group,
LG). Given the theoretical rationale for delivering obesity
treatment in a group format [12,13] along with previous
results indicating the potential benefits of smaller groups
[15,17,18], it was hypothesized that SG participants would
demonstrate greater weight loss, better treatment attend-
ance, better dietary self-monitoring adherence, and a more
positive attitude toward the group than LG participants.
Additionally, this study explored potential social (e.g., groupclimate) and behavioral (e.g., self-monitoring adherence)




Members of a health maintenance organization (HMO)
located in northern Florida were recruited for participa-
tion. HMO members were men and women who either
self-referred or received physician referral to the program.
HMO members were made aware of the study through
the HMO’s website, member newsletters, and during
physician office visits. Members attended an initial infor-
mation session, and interested members completed a brief
screening assessment by telephone to determine eligibility.
Participants were ≥21 years-old, had a body mass index
(BMI; kg/m2) between 30–45, and had current insurance
coverage through the HMO. Individuals were excluded if
they had lost >4.5 kg in the last six months, had a medical
condition likely to affect participation in physical activity,
planned to relocate from the coverage area in the next
12 months, were unable or unwilling to attend weekly
group sessions, or were unwilling to accept random as-
signment to treatment groups.
Among 103 individuals who attended the informational
session, 99 completed a subsequent telephone screening
and 70 were deemed eligible for participation. Of these, 68
individuals provided informed consent and completed a
baseline assessment at the medical center; however, two
individuals dropped out prior to treatment assignment.
Thus, 66 participants were randomly assigned to the treat-
ment conditions (Figure 1). Thirty-one individuals were
assigned to one LG, and 35 individuals were assigned to
one of three SGs (approximately 12 individuals/group).
Prior to recruitment, four meeting times for treatment
groups were determined based on availability of clinic staff
and space, and participants were asked to provide their
availability for each of the four times during the screening
process. After all participants provided availability, a com-
puterized random number generator was used to deter-
mine which of the four meetings would be small or large
groups. Participants were de-identified (represented by
study ID and meeting time availability only) in order for
staff to assign them to one of the four groups. Thus, the
research team was masked to the identity of participants
during treatment assignment (rather than being masked
to condition itself ) until all assignments had been made.
Approval for this study was obtained from the IRBs of
participating institutions.
Measures
Demographics and medical history
At baseline, participants reported their age, sex, race,
education level, marital status, and current tobacco and
Attended orientation session (n=103)
Completed phone screening (n=99)
Eligible for study (n=70)
Completed baseline assessment (n=68)








Could not be reached for 12-month assessment (n=3)
Refused 12-month assessment (n=1)








Dropped out prior to assignment (n=2)
Could not be reached for baseline assessment (n=2)
Excluded (n=29)
No longer interested (n=2)
Would not accept random assignment (n=1)
Lost > 4.5 kg in past 6 months (n=6)
Has medical condition (n=2)
BMI out of range (n=18)
Could not be reached for phone screening (n=4)
Figure 1 Screening, randomization, and assessments of study participants.
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no) of the following medical conditions: high blood pres-
sure, heart attack, chest pain, type 2 diabetes, gestational
diabetes, pre-diabetes, arthritis, sleep apnea, high choles-
terol, dizziness/fainting, asthma or chronic lung disease,
and orthopedic problems. The total number of medical
conditions was computed for each participant.Weight and height
Weight and height were measured at each assessment in
the medical clinic and used to calculate BMI. Weight was
measured to the nearest 0.1 kg using a calibrated digital
scale. Height was measured to the nearest 0.1 cm using a
wall-mounted stadiometer. For participants who failed to
complete the Month 6 and/or Month 12 assessment,
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health records (EHR). EHR weights were imputed if they
were recorded within an eight-week period (+/− four
weeks) of the study assessment. EHR weights were used
for six participants at Months 6 and 12.
Treatment attendance
Group leaders recorded participant attendance at group
sessions. If a participant missed a group session, an indi-
vidual make-up session was not provided, although the
participant received session materials for review.
Self-monitoring adherence
Participants were instructed to self-monitor food intake
using forms provided. Instructions included daily self-
monitoring during Months 0–6 (i.e., up to 168 days of
completed logs) and 3 days/week during Months 7–12
(i.e., up to 72 days of completed logs), which resulted in
a total possible 240 days of completed logs. A completed
log was defined as having at least two designated meals
or eating episodes recorded within the day.
Treatment climate
Participants completed the Group Climate Questionnaire-
Short Form (GCQ-S), a widely used measure of group
process [24], at Months 6 and 12. The GCQ-S consists of
12 items rated on a six-point scale. The GCQ-S provides
scores on three domains: Engagement, Conflict, and
Avoidance [24]. For each domain, higher scores indicate
higher perceived levels of that group process. The Engage-
ment scale measures the extent to which the working
group atmosphere is positive and cohesive. The Conflict
scale reflects the amount of interpersonal anger and fric-
tion in the group. The Avoidance scale measures the
extent of avoidance of responsibility for change by group
members. The GCQ-S has demonstrated satisfactory reli-
ability (Cronbach’s α ranging from 0.72-0.95) [25-27].
Study design
Treatment description
The 12-month intervention was modeled after the lifestyle
intervention of the Diabetes Prevention Program [28] and
the treatment protocols developed and evaluated by Perri
and colleagues [19]. Grounded in social-cognitive theory
[12], these interventions seek to enhance individuals’ so-
cial support, personal motivators, and self-efficacy for be-
havior change [5]. Further, they have demonstrated
efficacy for producing clinically meaningful weight reduc-
tion [19,29]. The format and content of sessions were the
same for both conditions. Participants received pedome-
ters, food scales, and measuring cups/spoons to facilitate
self-monitoring and behavior change, and group leaders
distributed self-monitoring logs at each session.During Months 0–6, participants attended 24 weekly
90-minute group sessions. Prior to each session, partici-
pants were weighed privately. Each session included pres-
entation, discussion, and practice of skills related to
nutrition, exercise, and other self-management strategies.
Participants also received training in self-monitoring,
problem-solving, stimulus control, cognitive restructuring,
and relapse prevention. Consistent with NHLBI guidelines
[30], participants were encouraged to work towards a 10%
reduction in body weight during the initial six-month
period. To achieve this goal, participants were instructed
to reduce caloric intake to 1,200 kcal/day (for participants
weighing <250 pounds) or 1,500 kcal/day (for participants
weighing ≥250 pounds). Participants were also encouraged
to increase levels of moderate-intensity physical activity to
180 minutes/week.
Participants attended six monthly extended care sessions
between Months 6–12. The purpose of extended-care was
to maintain adherence, bolster motivation, and reinforce in-
formation previously discussed with a focus on the main-
tenance of healthy lifestyle behaviors. All study-related
visits were held at one of the HMO outpatient clinics.
Intervention staff
All interventions were facilitated by a licensed clinical
psychologist with expertise in delivery of weight man-
agement programs and/or doctoral students in clinical
and counseling psychology. Each group included two co-
facilitators. The intervention team met weekly to discuss
all aspects of treatment delivery.
Statistical analyses
Descriptive statistics, including sample mean and sample
proportions, were used to summarize sample characteris-
tics. T-tests were used to compare population means, and
χ2 tests or Fisher’s exact tests were used to assess associ-
ation between categorical variables. To analyze the main
outcome of weight change over time while accounting for
the dependence among measurements of the same partici-
pant, we applied a mixed effects model with unstructured
covariance matrix and adjusted for baseline body weight.
Without imputation, this method allowed for participants
with missing measurements at either follow-up (n = 7 at
Month 6; n = 4 at Month 12) to be retained in analyses.
Comparison of attendance, adherence, and group climate
scores (i.e., Engagement, Conflict, and Avoidance scales of
the GCQ-S) for the SG and LG conditions were examined
using t-tests at Months 6 and 12. Cumulative attendance
was analyzed at Month 12.
Evaluating measures of group climate (i.e., Engagement,
Conflict, and Avoidance), attendance, and adherence as
potential mediators of the association between group as-
signment and weight change were proposed. To explore
this, additional regression analyses were conducted based
Table 1 Baseline characteristics of the total sample and
each treatment condition
Overall sample LG SG
(N = 66) (n = 31) (n = 35)
M (SD) M (SD) M (SD) p-value
Age 50.2 (10.7) 48.1 (11.8) 51.9 (9.5) 0.151
Weight (kg) 102.3 (20.0) 104.4 (24.2) 100.5 (15.4) 0.441
BMI (kg/m2) 36.5 (5.7) 36.9 (6.3) 36.1 (5.2) 0.586
# of medical
conditions
2.2 (1.8) 2.1 (1.6) 2.4 (2.0) 0.544
% % %
Female 86.4 83.9 88.6 0.724




51.5 41.9 60.0 0.143
Married 59.1 58.1 60.0 0.873
Current tobacco
use
4.6 6.5 2.9 0.597
Current alcohol
use
47.0 51.6 42.9 0.477
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Kenny [31] and recently updated by Cerin and MacKinnon
[32], as well as the multiple mediator modelling method de-
tailed by Preacher and Hayes [33]. In this approach, the
change between overall treatment effect and the residual
treatment effect of group size on weight change, after sim-
ultaneously accounting for the impact of the specified
mediator variables, were examined using the product-of-
coefficient estimate method. First, a test of the action the-
ory was performed examining the association between
treatment and the proposed mediators. For constructs
demonstrating a significant association with group size, a
test of the conceptual theory further assessed the relation-
ship between the mediators and the outcome (i.e., weight
change), while adjusting for the effect of treatment in the
model. In these analyses, baseline weight was included as a
confounder variable. For each mediator, the point estimator
of mediation effect was calculated as the product of the ac-
tion theory test and the conceptual theory test regression
coefficients. Due to small sample size and subsequent
skewed distributions of path effects, we obtained bias-
corrected bootstrap confidence intervals based on 10,000
bootstrap samples [32,34-36]. Also consistent with Cerin
and MacKinnon [32], multiple-mediator models were
employed, and mediation effect estimates were reported
in the units of the outcome variable (kg). Statistical ana-
lyses were conducted using SAS/STAT® software, Version




Participant characteristics are summarized in Table 1. The
majority of participants were women (86%), and nearly half
were African American (47%). There were no significant
differences between the LG and SG conditions for any of
the baseline characteristics assessed, ps > 0.05.
Effect of group size on weight loss
Participants in the LG condition lost an average of 3.2 kg
from Month 0–6, p = 0.004. However, participants in the
SG condition demonstrated an additional 3.2 kg of weight
loss (mean loss = −6.5 kg), representing a significant differ-
ence between the LG and SG conditions at Month 6,
p = 0.03. Participants in the LG condition experienced
weight regain between Months 6–12, such that their mean
weight at Month 12 was not significantly different from
baseline (mean loss from baseline = −1.7 kg), p = 0.15. In
contrast, SG participants continued to lose a small
amount of weight between Month 6–12, and their Month
12 weights remained significantly lower than baseline
(mean loss from baseline = −7.0 kg) and LG participants’
Month 12 weights (additional mean loss = −5.3 kg),
p = 0.001 (see Table 2 and Figure 2).When examining the proportion of participants in each
condition who achieved ≥ 5% weight loss, chi square ana-
lyses indicated that 57.6% of SG participants met this criter-
ion at Month 6 compared with 42.3% of LG participants,
which was a non-significant difference, p = 0.244. At Month
12, however, significantly more SG participants (51.4%)
achieved a ≥ 5% weight loss compared to LG participants
(25.9%), p = 0.042.Effect of group size on session attendance
Participants assigned to the SG condition attended ap-
proximately three more of the 24 weekly sessions than LG
participants during the first six months of the program, al-
though this was a non-significant difference, p = 0.095 (see
Table 3). This difference in attendance rates remained
when the six monthly extended care sessions offered
between Months 6–12 were included, with SG and LG
attendance rates of 18.6 and 14.7 (of 30 sessions), re-
spectively, p = 0.089.Effect of group size on self-monitoring adherence
SG participants completed significantly more days of
dietary self-monitoring than LG participants (mean dif-
ference = 39.4 days) during the first six months of treat-
ment, p = 0.004 (Table 3). SG participants also completed
more days of self-monitoring for the full 12 months of the
program (mean difference = 44.8 days), p = 0.007.
Table 2 Analysis of weight change (kg) at Months 6 and
12*
Independent variable Estimate Std Err p-value
LG mean baseline weight, kg (intercept) 104.39 3.60 <.0001
Difference in mean baseline weight
(SG – LG)
−3.93 4.94 0.4286
Month 6 mean weight loss in LG −3.22 1.08 0.0039
Month 6 additional mean weight
loss in SG
−3.23 1.46 0.0301
Month 12 mean weight loss in LG −1.70 1.17 0.1504
Month 12 additional mean weight
loss in SG
−5.33 1.58 0.0013
*Results are based on mixed effects model with unstructured covariance matrix.
Figure 2 Mean weight change over time by group.
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Based on scores from the Group Climate Questionnaire
(i.e., Engagement, Conflict, and Avoidance), results indi-
cated that SG participants reported experiencing signifi-
cantly better engagement in the treatment process than
LG participants, and this difference was observed for the
engagement scores at Months 6 and 12, ps < 0.04. The
two conditions did not differ on perception of the group’s
ability to effectively cope with conflict or avoid problems
during the course of treatment (Table 3).
Potential mediators of the association between group
size and weight loss
Additional analyses were conducted to examine whether
treatment engagement and/or adherence mediated the rela-
tionship between treatment condition and weight loss. Re-
sults of this multiple mediator analysis (Figure 3) indicated
that, compared to participants in the LG condition, those
in the SG condition completed self-monitoring on 35.66
Table 3 Comparison of SG and LG conditions on
treatment attendance, adherence, and group climate
SG LG p-value
Session attendance
Baseline – month 6a 15.8 (7.0) 12.8 (7.4) 0.0947
Baseline – month 12b 18.6 (8.8) 14.7 (9.2) 0.0892
Self-monitoring adherence
Baseline – month 6c 98.5 (47.3) 59.1 (56.8) 0.0042
Baseline – month 12d 113.0 (56.3) 68.2 (69.2) 0.0068
Group climate scorese
Engaged (baseline – month 6) 4.3 (0.9) 3.7 (0.9) 0.0371
Engaged (baseline – month 12) 4.2 (1.1) 3.2 (0.8) 0.0004
Conflict (baseline – month 6) 0.2 (0.3) 0.3 (0.4) 0.2164
Conflict (baseline – month 12) 0.2 (0.4) 0.4 (0.5) 0.0784
Avoidance (baseline – month 6) 2.7 (1.1) 2.4 (1.1) 0.3506
Avoidance (baseline – month 12) 2.6 (1.2) 2.7 (1.0) 0.7696
a of 24 sessions, b of 30 sessions, c of 168 days, d of 240 days, e score range = 0-6.
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weight loss, 95% CI (−0.07, −0.02), per each additional day
of self-monitoring. Thus, the product of mediation path ef-
fects specifically associated with adherence (i.e., group size-
to-adherence and adherence-to-weight loss) was −1.77 kg,
95% CI (−4.13, −0.14), indicating a significant additional
1.77 kg weight loss in SG attributable to this variable. Medi-
ation analysis also indicated that the average engagement
score of SG participants was 0.98 points, 95% CI (0.50,
1.40), higher than that of LG participants, although the















Figure 3 Self-monitoring adherence and engagement as mediators oincrease in engagement score was not significant, −0.31 kg,
95% CI (−2.24, 1.35). Hence, the indirect effect of group
size on weight loss through engagement was not significant
at −0.31 kg, 95% CI (−2.56, 1.27). The total indirect effect
of group size on weight change through the two mediators
was −2.09 kg, 95% CI (−4.76, −0.09), indicating the treat-
ment effect was significantly reduced after accounting for
these variables. In addition, simultaneous inclusion of the
proposed mediators of engagement and adherence reduced
the magnitude of the association between SG assignment
and weight loss from −4.94 kg, 95% CI (−8.28, −1.95) to a
non-significant value of −2.39 kg, 95% CI (−5.11, 0.33). In
summary, self-monitoring adherence fully mediated the
association between group size and weight loss, while treat-
ment engagement was not a significant mediator when also
accounting for adherence. Because group size was not sig-
nificantly associated with session attendance or the other
subscale scores from the group climate measure, these vari-
ables were not included in mediation analyses.
Discussion
The present study examined whether delivery of a 12-
month behavioral weight loss intervention in either “small”
or “large” group formats within a managed care setting im-
pacted weight loss outcomes. The primary finding demon-
strates that participants assigned to the SG condition lost
significantly more weight at both 6 and 12 months of the
intervention when compared to participants within the LG.
Participants in both groups achieved significant weight
losses at Month 6 (−6.4 kg for SG versus −3.2 kg for LG).











f the association between group size and weight change.
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significantly differ from baseline. Conversely, participants in
the SG demonstrated slight additional weight loss from
Months 6–12, such that by Month 12 they achieved a sig-
nificant average loss of −7.03 kg, which is comparable to
weight losses seen in other trials [29,38]. In addition, 51%
of SG participants attained a 5% weight loss compared to
only 26% in the LG at Month 12. A 5% body weight loss
has clinical significance, resulting in reduced risk factors for
diabetes and heart disease [29,38]. While group-based inter-
ventions have demonstrated superiority when compared to
individually-tailored delivery [6-8], this study further sug-
gests that delivery to smaller groups of approximately 12
participants, versus larger groups of approximately 30 par-
ticipants, results in more successful weight loss.
Both session attendance and self-monitoring adherence
are strongly associated with overall weight loss success in
lifestyle interventions for obesity [19-23]. SG participants
attended nearly four more sessions on average than LG
members, although this was a non-significant difference.
Additionally, adherence to self-monitoring differed signifi-
cantly between conditions, with higher rates of adherence
observed among SG participants. This difference in self-
monitoring adherence mediated the association between
group size and weight loss, such that the residual direct ef-
fects of group size were no longer significant after account-
ing for adherence. Smaller groups, as compared to larger
groups, may provide more opportunities for intervention-
ists and participants to reinforce the accuracy and comple-
tion of self-monitoring records, problem-solve barriers to
maintaining records, and set individualized goals for im-
proving adherence. Therefore, increased accountability in
smaller groups may promote greater adherence and con-
tribute to weight loss success.
Within the psychotherapy literature, smaller group size
is associated with increased social support [17] and group
cohesion [18]. Larger groups may limit potential resources
available and may cause individual members difficulties
in making connections, leading to feelings of isolation
or alienation [17]. In the present study, SG participants
endorsed a more positive and cohesive group atmosphere
than LG members, suggesting that smaller groups allow
for greater allocation of resources and improved oppor-
tunities for supportive interactions that foster an environ-
ment encouraging of weight loss. Treatment engagement
did not, however, mediate the association between group
size and weight loss after accounting for self-monitoring
adherence. While it is possible that the included measure
did not fully capture the most salient features of engage-
ment, the more robust influence of self-monitoring ad-
herence may have also contributed to these findings.
According to social-cognitive theory [12], the cohesive
bonds and meaningful interactions experienced among
SG participants may have promoted increases in self-efficacy for weight loss behaviors, such as self-monitoring
[13]. Indeed, members who feel connected within their
group have demonstrated greater responses to group treat-
ment, such as an increased willingness to disclose during
discussion [39], higher goal attainment [40], and better at-
tendance rates [41,42].
This study did have limitations. First, group members
were recruited solely within HMOs, with the sample being
comprised mainly of females (86%). While the sample was
racially and educationally diverse, generalizability remains
limited to other clinical settings. Second, the sample size
was modest and may have been inadequately powered to
detect some group differences. Third, the study timeline
lasted one year. While participants in the SG continued to
lose a small amount of weight from Months 6–12, it re-
mains unclear whether this trend would continue in the
long-term. Fourth, the LG condition included only one
treatment group, while the SG condition included three
groups that were combined for analyses. Thus, there was
a potential cluster effect not fully accounted for by the
analyses, as the inclusion of a single LG prohibited esti-
mating random effects attributable to cluster (i.e., random
cluster effect could not be separated from the treatment
effect for the LG). Fifth, this trial only compared groups of
approximately 12 versus 30 members, so the relative ef-
fects of moderate-sized groups (e.g., 15–30 participants) is
unknown. Finally, while self-monitoring adherence fully
mediated the association between group size and weight
loss, there may be other process variables not assessed
that additionally account for the weight change differences
observed between the LG and SG conditions.
While this study provides novel information on the treat-
ment effects of LG and SG conditions, cost-effectiveness of
the two approaches was not evaluated. Even though SG
participants achieved greater weight loss, it is important to
consider whether LG treatment delivery remains a viable
option from a cost-efficiency perspective. By formally meas-
uring and calculating program operation costs (e.g., inter-
ventionist and administrator time, meeting space fees, etc.),
future research could determine costs per kg of weight lost,
or a similar metric of cost-effectiveness, to select the appro-
priate group size that maximizes weight loss at the lowest
costs.
The present study also had a number of strengths. The
trial utilized a randomized design, and retention was ex-
cellent with approximately 94% of participants contribut-
ing weight data at Month 12. In addition, all participants
received a structured lifestyle intervention modeled after
evidence-based protocols [19,28], which incorporated
state-of-the-art behavioral principles to promote weight
loss and maintenance. Given the nature of the HMO set-
ting, access to electronic health records provided objective
weight data for participants who did not attend follow-up
study assessment visits.
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offers important clinical implications for the delivery of be-
havioral weight loss treatment. There may be a perceived
benefit to delivering evidence-based weight loss treatment
to larger numbers of participants in clinical settings to effi-
ciently use the limited resources available. However, this
study suggests that clinicians and administrators may need
to balance this potential advantage with the improved
weight loss outcomes achieved by delivering treatment in
smaller groups. Recently, researchers have investigated al-
ternate, more cost-effective methods of weight loss inter-
vention delivery, including group phone calls [6] and group
internet-based programs [43]. Utilizing these alternative
methods may retain group cohesiveness while incorpor-
ating more cost-effective modes of delivery and reducing
burden on staff and organizational resources. Future studies
should continue to assess whether alternative methods of
delivery prove superior for weight loss, cost-effectiveness,
and dissemination when delivered to traditional groups of
8–15 participants.
Conclusions
To our knowledge, the present study represents the first
empirical test of the effects of group size on weight loss
outcomes. The findings suggest that providing lifestyle
intervention for obesity in traditional groups of approxi-
mately 12 participants is superior to delivery in larger
groups of 30 or more participants. Participants in the
smaller groups achieved larger weight losses and were
more likely to attain a clinically significant weight loss
of ≥ 5%. A smaller group size also resulted in higher per-
ceived group engagement, suggesting that smaller group
settings provide more positive, cohesive, and collabora-
tive atmospheres. Small groups also facilitated greater
adherence to behavioral weight management strategies
(i.e., self-monitoring), and this behavior mediated the re-
lationship between group size and treatment outcomes.
Future studies should continue to investigate the utilization
of smaller group sizes with alternative modes of delivery
(e.g., telephone, internet) to improve cost effectiveness
within managed care and other applied clinical settings.
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